We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHO icon
3026
Sunstone Hotel Investors
SHO
$2.02B
$380K ﹤0.01%
40,359
+4,804
+14% +$51.9K
ALLO icon
3027
Allogene Therapeutics
ALLO
$683M
$379K ﹤0.01%
+35,138
New +$477K
EUSB icon
3028
iShares ESG Advanced Universal USD Bond ETF
EUSB
$713M
$379K ﹤0.01%
9,047
+1,803
+25% +$79K
RJET
3029
Republic Airways Holdings
RJET
$964M
$379K ﹤0.01%
15,316
-4,192
-21% -$144K
PATH icon
3030
UiPath
PATH
$8.64B
$378K ﹤0.01%
29,956
-208,926
-87% -$3.66M
ERIC icon
3031
Ericsson
ERIC
$33.6B
$377K ﹤0.01%
65,754
-75,025
-53% -$538K
FCEL icon
3032
FuelCell Energy
FCEL
$1.63B
$376K ﹤0.01%
3,678
-845
-19% -$101K
OII icon
3033
Oceaneering
OII
$5.11B
$376K ﹤0.01%
47,261
+1,512
+3% +$14.2K
BRKL
3034
DELISTED
Brookline Bancorp
BRKL
$375K ﹤0.01%
32,153
+984
+3% +$13K
CPRX
3035
DELISTED
Catalyst Pharmaceutical
CPRX
$375K ﹤0.01%
29,200
+6,876
+31% +$81.5K
SPE
3036
Special Opportunities Fund
SPE
$145M
$374K ﹤0.01%
35,312
+2,707
+8% +$32.8K
DRUP icon
3037
GraniteShares Nasdaq Select Disruptors ETF
DRUP
$53M
$373K ﹤0.01%
11,806
-1,130
-9% -$39.7K
AGNT
3038
AGNT Inc
AGNT
$752M
$373K ﹤0.01%
33,300
+3,894
+13% +$54.3K
AUDC icon
3039
AudioCodes
AUDC
$253M
$372K ﹤0.01%
17,062
+1,271
+8% +$28.6K
HL icon
3040
Hecla Mining
HL
$11.9B
$372K ﹤0.01%
94,325
+46,418
+97% +$189K
UVSP icon
3041
Univest Financial
UVSP
$1.19B
$372K ﹤0.01%
15,848
+1,692
+12% +$42.7K
UVV icon
3042
Universal Corp
UVV
$1.12B
$371K ﹤0.01%
8,054
+938
+13% +$49.1K
AMJ
3043
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$371K ﹤0.01%
18,507
-64
-0.3% -$1.34K
CHCO icon
3044
City Holding Co
CHCO
$2.08B
$370K ﹤0.01%
4,176
-1,841
-31% -$157K
NUMG icon
3045
Nuveen ESG Mid-Cap Growth ETF
NUMG
$376M
$369K ﹤0.01%
11,182
+543
+5% +$20K
MDRX
3046
DELISTED
Veradigm Inc. Common Stock
MDRX
$369K ﹤0.01%
24,253
+4,694
+24% +$75.9K
QS icon
3047
QuantumScape Corp
QS
$3.79B
$368K ﹤0.01%
43,716
+4,181
+11% +$44.8K
RXI icon
3048
iShares Global Consumer Discretionary ETF
RXI
$274M
$368K ﹤0.01%
3,017
-32
-1% -$4.35K
RFI
3049
Cohen & Steers Total Return Realty Fund
RFI
$309M
$367K ﹤0.01%
30,382
+758
+3% +$10.6K
PAPR icon
3050
Innovator US Equity Power Buffer ETF April
PAPR
$962M
$366K ﹤0.01%
13,760
-2,415
-15% -$67.3K

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.